247 related articles for article (PubMed ID: 24962189)
1. Hyperinsulinemic syndrome: the metabolic syndrome is broader than you think.
Kelly CT; Mansoor J; Dohm GL; Chapman WH; Pender JR; Pories WJ
Surgery; 2014 Aug; 156(2):405-11. PubMed ID: 24962189
[TBL] [Abstract][Full Text] [Related]
2. Calorie restriction is a major determinant of the short-term metabolic effects of gastric bypass surgery in obese type 2 diabetic patients.
Lips MA; de Groot GH; van Klinken JB; Aarts E; Berends FJ; Janssen IM; Van Ramshorst B; Van Wagensveld BA; Swank DJ; Van Dielen F; Willems van Dijk K; Pijl H
Clin Endocrinol (Oxf); 2014 Jun; 80(6):834-42. PubMed ID: 23711328
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
Reaven GM
Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review.
Giovannucci E
Am J Clin Nutr; 2007 Sep; 86(3):s836-42. PubMed ID: 18265477
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome, hyperinsulinemia, and cancer.
Hsu IR; Kim SP; Kabir M; Bergman RN
Am J Clin Nutr; 2007 Sep; 86(3):s867-71. PubMed ID: 18265480
[TBL] [Abstract][Full Text] [Related]
6. Associations of vitamin D with insulin resistance, obesity, type 2 diabetes, and metabolic syndrome.
Wimalawansa SJ
J Steroid Biochem Mol Biol; 2018 Jan; 175():177-189. PubMed ID: 27662816
[TBL] [Abstract][Full Text] [Related]
7. Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a controlled, population-based study.
Korhonen S; Hippeläinen M; Niskanen L; Vanhala M; Saarikoski S
Am J Obstet Gynecol; 2001 Feb; 184(3):289-96. PubMed ID: 11228476
[TBL] [Abstract][Full Text] [Related]
8. Hyperinsulinemia and cardiovascular risk.
Arrants J
Heart Lung; 1994; 23(2):118-22; 123-4. PubMed ID: 8206768
[TBL] [Abstract][Full Text] [Related]
9. Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index.
Ruge T; Lockton JA; Renstrom F; Lystig T; Sukonina V; Svensson MK; Eriksson JW
Metabolism; 2009 Jun; 58(6):860-6. PubMed ID: 19375766
[TBL] [Abstract][Full Text] [Related]
10. Fasting hyperinsulinemia associates with increased sub-clinical inflammation in first-degree relatives normal glucose tolerant women independently of the metabolic syndrome.
Setola E; Monti LD; Lucotti P; Galluccio E; Oldani M; Bosi E; Piatti P
Diabetes Metab Res Rev; 2009 Oct; 25(7):639-46. PubMed ID: 19685554
[TBL] [Abstract][Full Text] [Related]
11. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
Jeanes YM; Reeves S
Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
[TBL] [Abstract][Full Text] [Related]
12. Hyperinsulinemia, insulin resistance, and hypertension.
Bönner G
J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S39-49. PubMed ID: 7898093
[TBL] [Abstract][Full Text] [Related]
13. Mediators of sympathetic activation in metabolic syndrome obesity.
Straznicky NE; Eikelis N; Lambert EA; Esler MD
Curr Hypertens Rep; 2008 Dec; 10(6):440-7. PubMed ID: 18959829
[TBL] [Abstract][Full Text] [Related]
14. Serum preadipocyte factor-1 concentrations in females with obesity and type 2 diabetes mellitus: the influence of very low calorie diet, acute hyperinsulinemia, and fenofibrate treatment.
Kavalkova P; Touskova V; Roubicek T; Trachta P; Urbanova M; Drapalova J; Haluzikova D; Mraz M; Novak D; Matoulek M; Lacinova Z; Haluzik M
Horm Metab Res; 2013 Oct; 45(11):820-6. PubMed ID: 23979788
[TBL] [Abstract][Full Text] [Related]
15. Effects of chronic hyperinsulinemia in insulin-resistant patients.
Muntoni S; Muntoni S; Draznin B
Curr Diab Rep; 2008 Jun; 8(3):233-8. PubMed ID: 18625122
[TBL] [Abstract][Full Text] [Related]
16. [Pathogenic role of hyperinsulinism in macroangiopathy. Epidemiological data].
Valensi P
Presse Med; 1992 Sep; 21(28):1307-11. PubMed ID: 1438099
[TBL] [Abstract][Full Text] [Related]
17. Hemostatic abnormalities associated with obesity and the metabolic syndrome.
Reaven GM; Scott EM; Grant PJ; Lowe GD; Rumley A; Wannamethee SG; Stratmann B; Tschoepe D; Blann A; Juhan-Vague I; Alessi MC; Bailey C
J Thromb Haemost; 2005 May; 3(5):1074-85. PubMed ID: 15869606
[No Abstract] [Full Text] [Related]
18. [Role of abdominal obesity in pathogenesis of insulin resistance syndrome].
Almazov VA; Blagosklonnaia IaV; Shliakhto EV; Krasil'nikova EI
Ter Arkh; 1999; 71(10):18-22. PubMed ID: 10612167
[TBL] [Abstract][Full Text] [Related]
19. [Insulin resistance/hyperinsulinemia associated diseases not included in the metabolic syndrome].
Carvalheira JB; Saad MJ
Arq Bras Endocrinol Metabol; 2006 Apr; 50(2):360-7. PubMed ID: 16767302
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance in prepubertal obese children correlates with sex-dependent early onset metabolomic alterations.
Mastrangelo A; Martos-Moreno GÁ; García A; Barrios V; Rupérez FJ; Chowen JA; Barbas C; Argente J
Int J Obes (Lond); 2016 Oct; 40(10):1494-1502. PubMed ID: 27163744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]